Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER Study: Remimazolam vs Midazolam for Endoscopy Sedation
jRCTs071240062Completed
- Sponsor
- Mundipharma
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial comparing Remimazolam sedation with Midazolam sedation (2 arms). Primary endpoint: Good ambulation at 5 minutes after endoscopy. Started Sep 2024; status: completed.
02
Drugs
remimazolammidazolam
Beyond the preview
Go deeper on jRCTs071240062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071240062.